PD-L1

Open Access
CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms
UMAR WAZIR, AMBER X. LI, CAROLYN CAI WANG, HENSON HAN GAO, TRACEY A. MARTIN, WEN G. JIANG and KEFAH MOKBEL

Cancer Genomics & Proteomics July 2025, 22 (4) 557-563; DOI: https://doi.org/10.21873/cgp.20521
Open Access
Expression of PD-L1 Is Increased by Methionine Restriction Using Recombinant Methioninase in Human Colorectal Cancer Cells
KOHEI MIZUTA, BYUNG MO KANG, QINGHONG HAN, YUTARO KUBOTA, SEI MORINAGA, MOTOKAZU SATO, MICHAEL BOUVET, YASUNORI TOME, KOTARO NISHIDA and ROBERT M. HOFFMAN

Cancer Genomics & Proteomics July 2024, 21 (4) 395-398; DOI: https://doi.org/10.21873/cgp.20457
Open Access
Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma
YOHEI OKUDA, TAIGO KATO, KAZUTOSHI FUJITA, HIROAKI FUSHIMI, HIROSHI MIYAMOTO, GEORGE J. NETTO and NORIO NONOMURA

Cancer Genomics & Proteomics March 2024, 21 (2) 137-143; DOI: https://doi.org/10.21873/cgp.20435

Main menu